Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
ASCO
Pharma
ASCO: Will Seagen's Adcetris be a growing force in lymphoma?
At ASCO, Seagen and Takeda presented trial data that show Adcetris could become at growing force in the treatment of various forms of lymphoma.
Kevin Dunleavy
May 26, 2022 5:00pm
Bayer hikes Nubeqa's peak sales to over €3B amid 3-way battle
Feb 17, 2022 4:32pm
Zejula gives J&J mixed success in prostate cancer
Feb 14, 2022 5:00pm
Is pharma ready to talk cure in cancer? AZ convenes panel debate
Jun 1, 2021 11:28am
Exelixis highlights the Cabometyx thyroid cancer phase 3 data
May 19, 2021 5:01pm
Is Keytruda-Lenvima the winner in kidney cancer?
Feb 17, 2021 4:08pm
